Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04885985

ACOART BTK RENEW:A Post Market Clinical Study

A Post Market Clinical Study to Evaluate the Safety and Efficacy of the Acotec Drug-coated Balloon in the Treatment of the Below-the-knee Artery

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
107 (estimated)
Sponsor
Acotec Scientific Co., Ltd · Industry
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The objective of this prospective, multi-center, single arm study is to obtain further data on the safety and performance of the Acotec Litos\&Tulip Drug-coated Balloon catheters in the treatment of lesions in below-the-knee artery.

Conditions

Interventions

TypeNameDescription
DEVICEDEB catheterTrade name of DEB catheter: AcoArt Tulip (0.018") or AcoArt Litos (0.014")

Timeline

Start date
2021-12-31
Primary completion
2024-08-01
Completion
2027-04-01
First posted
2021-05-13
Last updated
2024-08-01

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04885985. Inclusion in this directory is not an endorsement.

ACOART BTK RENEW:A Post Market Clinical Study (NCT04885985) · Clinical Trials Directory